Last Updated : Nov 02, 2020 10:13 PM IST | Source: PTI

Karnataka's COVID tally at 8.29 lakh with 2,576 fresh cases, 29 deaths

The total infections comprised 7,73,595 discharges, including 8,334 on Monday, and 44,805 active cases, including 931 in the intensive care units (ICUs) of various hospitals, a bulletin issued by the health department said.

PTI

With 2,576 fresh cases and 29 deaths, Karnataka's COVID-19 tally and cumulative fatalities reached 8,29,640 and 11,221 respectively on November 2, the health department said.

The state has been showing steady decline in cases and mortalities in recent days from an alarming over 10,000 infections and around 200 fatalities a day about a month ago.

Sharing the encouraging trends, state Health Minister Dr K Sudhakar tweeted, "2,576 new Covid cases have been reported in Karnataka today and 8,334 recoveries.7,73,595 people have recovered in the state so far with a recovery rate of 93.24%. State's covid mortality rate stands at 1.35%."

Close

He went on to say "Victory is ours in the fight against coronavirus!" and added it would happen if people followed the three precautions of wearing masks, clean hands, and social distance.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

related news

The total infections comprised 7,73,595 discharges, including 8,334 on Monday, and 44,805 active cases, including 931 in the intensive care units (ICUs) of various hospitals, a bulletin issued by the health department said.

About 50 per cent of the fresh cases and fatalities were contributed by the Bengaluru Urban district with 1,439 infections and 14 deaths.

Cumulatively, the city has reported 3,40,075 infections, 3,888 deaths and 3,10,088 discharges, including 5,925 on Monday. It has 26,098 active cases. According to the bulletin, as many as 123 cases were reported in Tumakuru, 100 in Mysuru, 92 in Mandya, 87 in Hassan, 60 in Ballari, 58 in Chikkaballapura and 51 in Dakshina Kannada and rest were scattered over other districts.

Most of those who died of coronavirus were above 50 years of age but there were three people in their 40s and two in their 30s, it said. A total of 78,496 tests, including 65,015 using the RT PCR method, were done, taking the cumulative number of specimens screened so far to 80.91 lakh.

Follow our full coverage of the coronavirus pandemic here.
First Published on Nov 2, 2020 10:12 pm

tags #coronavirus #Current Affairs #India #Karnataka